Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Microbial Sensitivity Tests | 33 | 2024 | 1866 | 5.350 |
Why?
|
Anti-Bacterial Agents | 35 | 2024 | 7136 | 4.550 |
Why?
|
Enterobacteriaceae | 8 | 2018 | 168 | 3.440 |
Why?
|
Nebramycin | 5 | 2019 | 10 | 3.180 |
Why?
|
Drug Resistance, Multiple, Bacterial | 13 | 2022 | 563 | 2.160 |
Why?
|
Legionella pneumophila | 7 | 2017 | 46 | 2.010 |
Why?
|
Brucella | 3 | 2019 | 10 | 1.990 |
Why?
|
Colistin | 4 | 2022 | 47 | 1.690 |
Why?
|
Klebsiella pneumoniae | 6 | 2023 | 244 | 1.680 |
Why?
|
Anti-Infective Agents | 4 | 2024 | 973 | 1.680 |
Why?
|
High-Throughput Screening Assays | 5 | 2020 | 953 | 1.650 |
Why?
|
Candida | 3 | 2021 | 171 | 1.610 |
Why?
|
Enterobacteriaceae Infections | 5 | 2020 | 181 | 1.550 |
Why?
|
Neisseria gonorrhoeae | 4 | 2024 | 238 | 1.480 |
Why?
|
Bacteriological Techniques | 5 | 2013 | 277 | 1.440 |
Why?
|
Acinetobacter baumannii | 4 | 2020 | 106 | 1.440 |
Why?
|
Automation, Laboratory | 3 | 2020 | 99 | 1.400 |
Why?
|
Bacteria | 5 | 2022 | 2106 | 1.280 |
Why?
|
Drug Synergism | 8 | 2022 | 1792 | 1.270 |
Why?
|
Microbiological Techniques | 2 | 2019 | 101 | 1.200 |
Why?
|
Bacteremia | 4 | 2024 | 957 | 1.190 |
Why?
|
beta-Lactamases | 7 | 2023 | 295 | 1.180 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2021 | 603 | 1.170 |
Why?
|
Carbapenems | 4 | 2023 | 114 | 1.050 |
Why?
|
Bacterial Infections | 5 | 2019 | 1391 | 1.040 |
Why?
|
Blood | 5 | 2017 | 597 | 0.990 |
Why?
|
Gonorrhea | 4 | 2024 | 335 | 0.940 |
Why?
|
Streptothricins | 1 | 2023 | 6 | 0.930 |
Why?
|
Drug Resistance, Bacterial | 4 | 2019 | 1031 | 0.850 |
Why?
|
Phagosomes | 3 | 2019 | 194 | 0.840 |
Why?
|
Specimen Handling | 4 | 2021 | 692 | 0.840 |
Why?
|
Zoonoses | 2 | 2024 | 184 | 0.830 |
Why?
|
Microscopy | 5 | 2018 | 899 | 0.810 |
Why?
|
Pseudomonas aeruginosa | 3 | 2018 | 1208 | 0.800 |
Why?
|
Reagent Kits, Diagnostic | 2 | 2014 | 230 | 0.790 |
Why?
|
Staphylococcus aureus | 3 | 2018 | 1449 | 0.780 |
Why?
|
Laboratory Chemicals | 1 | 2020 | 2 | 0.770 |
Why?
|
Chlamydia trachomatis | 2 | 2014 | 246 | 0.760 |
Why?
|
Steam | 1 | 2020 | 29 | 0.750 |
Why?
|
Staphylococcal Infections | 3 | 2018 | 1403 | 0.740 |
Why?
|
Clinical Laboratory Techniques | 3 | 2020 | 744 | 0.730 |
Why?
|
Decontamination | 1 | 2020 | 69 | 0.730 |
Why?
|
Quality Control | 2 | 2020 | 842 | 0.730 |
Why?
|
Spectinomycin | 1 | 2019 | 9 | 0.710 |
Why?
|
beta-Lactam Resistance | 2 | 2017 | 76 | 0.700 |
Why?
|
Streptococcal Infections | 1 | 2024 | 635 | 0.690 |
Why?
|
Communicable Diseases | 2 | 2020 | 873 | 0.690 |
Why?
|
Fever | 2 | 2017 | 1607 | 0.690 |
Why?
|
Brucellosis | 1 | 2018 | 19 | 0.680 |
Why?
|
Computer Peripherals | 1 | 2019 | 38 | 0.670 |
Why?
|
Headache | 2 | 2017 | 1199 | 0.670 |
Why?
|
Chlamydia Infections | 2 | 2014 | 364 | 0.670 |
Why?
|
Lung Diseases, Fungal | 2 | 2017 | 122 | 0.670 |
Why?
|
Ceftazidime | 1 | 2018 | 67 | 0.650 |
Why?
|
Malaria, Falciparum | 2 | 2017 | 1066 | 0.650 |
Why?
|
Azabicyclo Compounds | 1 | 2018 | 66 | 0.640 |
Why?
|
Phenazines | 1 | 2018 | 58 | 0.640 |
Why?
|
Gentian Violet | 1 | 2018 | 31 | 0.640 |
Why?
|
Masks | 1 | 2020 | 194 | 0.620 |
Why?
|
Amikacin | 1 | 2017 | 48 | 0.610 |
Why?
|
Technology, Pharmaceutical | 1 | 2017 | 85 | 0.600 |
Why?
|
Macrophages | 5 | 2019 | 5631 | 0.600 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2021 | 323 | 0.590 |
Why?
|
Bartonella | 2 | 2010 | 12 | 0.590 |
Why?
|
Membrane Transport Proteins | 1 | 2023 | 1028 | 0.590 |
Why?
|
Tobramycin | 1 | 2017 | 69 | 0.590 |
Why?
|
Bacterial Vaccines | 1 | 2019 | 402 | 0.590 |
Why?
|
Thigh | 1 | 2018 | 249 | 0.570 |
Why?
|
Eukaryotic Cells | 2 | 2016 | 198 | 0.570 |
Why?
|
Blastomyces | 1 | 2016 | 10 | 0.570 |
Why?
|
Escherichia coli | 5 | 2023 | 4220 | 0.570 |
Why?
|
Blastomycosis | 1 | 2016 | 16 | 0.560 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 691 | 0.550 |
Why?
|
Candidiasis | 2 | 2017 | 365 | 0.550 |
Why?
|
Gentamicins | 1 | 2017 | 253 | 0.550 |
Why?
|
Fever of Unknown Origin | 1 | 2016 | 93 | 0.540 |
Why?
|
Cephalosporins | 1 | 2016 | 204 | 0.530 |
Why?
|
Equipment Contamination | 1 | 2017 | 182 | 0.530 |
Why?
|
Influenza, Human | 2 | 2021 | 1476 | 0.530 |
Why?
|
Mediastinal Diseases | 1 | 2015 | 89 | 0.520 |
Why?
|
Limit of Detection | 5 | 2022 | 264 | 0.520 |
Why?
|
Cryptococcus | 1 | 2014 | 29 | 0.510 |
Why?
|
Public Policy | 1 | 2019 | 570 | 0.500 |
Why?
|
Small Molecule Libraries | 2 | 2019 | 728 | 0.480 |
Why?
|
Aminoglycosides | 3 | 2020 | 159 | 0.480 |
Why?
|
Cryptococcosis | 1 | 2014 | 101 | 0.480 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3143 | 0.470 |
Why?
|
Lymphatic Diseases | 1 | 2015 | 324 | 0.470 |
Why?
|
DNA Replication | 1 | 2020 | 1389 | 0.470 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 1374 | 0.470 |
Why?
|
Rib Fractures | 1 | 2014 | 130 | 0.450 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1066 | 0.440 |
Why?
|
Sensitivity and Specificity | 11 | 2021 | 14740 | 0.430 |
Why?
|
Cough | 1 | 2016 | 552 | 0.430 |
Why?
|
Cytoplasm | 1 | 2016 | 1536 | 0.410 |
Why?
|
Bacterial Proteins | 8 | 2023 | 3866 | 0.410 |
Why?
|
Gram-Negative Bacteria | 2 | 2023 | 270 | 0.400 |
Why?
|
Autophagy | 1 | 2019 | 1295 | 0.400 |
Why?
|
Bartonella Infections | 1 | 2010 | 22 | 0.370 |
Why?
|
Disease Outbreaks | 2 | 2017 | 1779 | 0.370 |
Why?
|
Klebsiella Infections | 2 | 2023 | 136 | 0.370 |
Why?
|
Nasopharynx | 3 | 2021 | 378 | 0.360 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2009 | 71 | 0.360 |
Why?
|
Fluorescent Dyes | 2 | 2015 | 1925 | 0.350 |
Why?
|
Fusidic Acid | 2 | 2019 | 15 | 0.350 |
Why?
|
Disease Models, Animal | 3 | 2018 | 18003 | 0.350 |
Why?
|
Humans | 69 | 2024 | 739398 | 0.340 |
Why?
|
Immunocompromised Host | 3 | 2016 | 845 | 0.330 |
Why?
|
Minocycline | 3 | 2022 | 164 | 0.320 |
Why?
|
Population Surveillance | 1 | 2019 | 2629 | 0.320 |
Why?
|
Acinetobacter Infections | 2 | 2020 | 68 | 0.320 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3248 | 0.310 |
Why?
|
Coagulase | 1 | 2007 | 54 | 0.300 |
Why?
|
Mycobacterium | 1 | 2009 | 249 | 0.300 |
Why?
|
Public Health | 2 | 2022 | 2587 | 0.300 |
Why?
|
Pneumocystis carinii | 1 | 2007 | 71 | 0.300 |
Why?
|
Predictive Value of Tests | 5 | 2017 | 15036 | 0.290 |
Why?
|
Bacterial Toxins | 3 | 2018 | 938 | 0.290 |
Why?
|
HIV Seronegativity | 1 | 2007 | 209 | 0.280 |
Why?
|
Macrolides | 2 | 2019 | 198 | 0.280 |
Why?
|
Rifampin | 2 | 2018 | 314 | 0.280 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2007 | 244 | 0.270 |
Why?
|
beta-Lactams | 2 | 2019 | 155 | 0.270 |
Why?
|
Laboratories | 2 | 2020 | 458 | 0.270 |
Why?
|
Histocytochemistry | 2 | 2018 | 723 | 0.270 |
Why?
|
Anthrax | 1 | 2006 | 87 | 0.270 |
Why?
|
Fluoroquinolones | 2 | 2019 | 306 | 0.260 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6478 | 0.260 |
Why?
|
Sputum | 1 | 2007 | 474 | 0.260 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2009 | 459 | 0.260 |
Why?
|
Antigens, Viral | 1 | 2009 | 1033 | 0.260 |
Why?
|
Bartonella henselae | 1 | 2004 | 16 | 0.260 |
Why?
|
Endothelial Cells | 3 | 2008 | 3435 | 0.250 |
Why?
|
Haiti | 2 | 2017 | 550 | 0.250 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2018 | 3344 | 0.250 |
Why?
|
Cell Line | 6 | 2019 | 15987 | 0.240 |
Why?
|
Lymph Nodes | 1 | 2015 | 3454 | 0.240 |
Why?
|
Drug Combinations | 2 | 2019 | 1959 | 0.230 |
Why?
|
Streptococcus | 1 | 2024 | 196 | 0.230 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 8977 | 0.220 |
Why?
|
Azithromycin | 2 | 2018 | 194 | 0.210 |
Why?
|
Animals | 17 | 2024 | 168368 | 0.210 |
Why?
|
Cellulitis | 1 | 2024 | 206 | 0.210 |
Why?
|
Automation | 2 | 2017 | 584 | 0.210 |
Why?
|
Cell Division | 3 | 2023 | 4575 | 0.210 |
Why?
|
HIV Seropositivity | 1 | 2007 | 966 | 0.200 |
Why?
|
Influenza B virus | 1 | 2021 | 49 | 0.200 |
Why?
|
Gene Transfer, Horizontal | 1 | 2022 | 145 | 0.200 |
Why?
|
Polymerase Chain Reaction | 4 | 2021 | 6174 | 0.200 |
Why?
|
Time | 2 | 2021 | 528 | 0.190 |
Why?
|
Sterilization | 2 | 2020 | 134 | 0.190 |
Why?
|
Fishes | 1 | 2024 | 563 | 0.190 |
Why?
|
Travel | 2 | 2017 | 787 | 0.190 |
Why?
|
Microwaves | 2 | 2020 | 188 | 0.190 |
Why?
|
Equipment Reuse | 1 | 2020 | 42 | 0.190 |
Why?
|
Ribosome Subunits | 1 | 2020 | 3 | 0.190 |
Why?
|
Diagnostic Tests, Routine | 3 | 2021 | 789 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2021 | 10945 | 0.180 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2016 | 765 | 0.180 |
Why?
|
Lincosamides | 1 | 2019 | 4 | 0.180 |
Why?
|
DNA | 1 | 2014 | 7275 | 0.180 |
Why?
|
Mice, Inbred BALB C | 2 | 2019 | 6397 | 0.180 |
Why?
|
Disinfection | 2 | 2020 | 189 | 0.180 |
Why?
|
Ribosomes | 1 | 2023 | 499 | 0.180 |
Why?
|
Diarrhea | 2 | 2017 | 1342 | 0.180 |
Why?
|
Filtration | 1 | 2020 | 235 | 0.170 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2023 | 946 | 0.170 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2021 | 136 | 0.170 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2021 | 326 | 0.170 |
Why?
|
Mononuclear Phagocyte System | 1 | 2018 | 56 | 0.170 |
Why?
|
Amines | 1 | 2020 | 277 | 0.170 |
Why?
|
Fosfomycin | 2 | 2016 | 25 | 0.170 |
Why?
|
Escherichia coli Infections | 1 | 2023 | 529 | 0.170 |
Why?
|
X Chromosome | 2 | 2020 | 815 | 0.170 |
Why?
|
Plasmids | 2 | 2022 | 2307 | 0.170 |
Why?
|
Urinary Tract Infections | 2 | 2022 | 766 | 0.170 |
Why?
|
Pandemics | 5 | 2022 | 8274 | 0.170 |
Why?
|
Printing | 1 | 2018 | 46 | 0.160 |
Why?
|
Apoptosis | 3 | 2006 | 9714 | 0.160 |
Why?
|
Community Networks | 1 | 2020 | 203 | 0.160 |
Why?
|
Molecular Structure | 2 | 2021 | 1925 | 0.160 |
Why?
|
Methicillin | 1 | 2018 | 61 | 0.160 |
Why?
|
Mammals | 1 | 2024 | 1112 | 0.160 |
Why?
|
Aztreonam | 1 | 2017 | 10 | 0.160 |
Why?
|
Glycopeptides | 1 | 2019 | 223 | 0.160 |
Why?
|
Mice | 11 | 2023 | 81002 | 0.160 |
Why?
|
Reproducibility of Results | 4 | 2020 | 19811 | 0.160 |
Why?
|
Bacterial Load | 1 | 2018 | 153 | 0.160 |
Why?
|
Antigens, Bacterial | 1 | 2004 | 1170 | 0.160 |
Why?
|
Influenza A virus | 1 | 2021 | 461 | 0.160 |
Why?
|
rab GTP-Binding Proteins | 1 | 2019 | 247 | 0.150 |
Why?
|
Coccidioidomycosis | 1 | 2017 | 36 | 0.150 |
Why?
|
Methicillin Resistance | 1 | 2018 | 198 | 0.150 |
Why?
|
R Factors | 1 | 2017 | 44 | 0.150 |
Why?
|
Drug Repositioning | 1 | 2019 | 232 | 0.150 |
Why?
|
Spectrum Analysis | 1 | 2019 | 450 | 0.150 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1721 | 0.150 |
Why?
|
Saliva | 1 | 2021 | 805 | 0.150 |
Why?
|
Microbial Interactions | 1 | 2017 | 77 | 0.140 |
Why?
|
Antifungal Agents | 1 | 2021 | 722 | 0.140 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 567 | 0.140 |
Why?
|
Luminescent Measurements | 1 | 2018 | 405 | 0.140 |
Why?
|
Whole Body Imaging | 1 | 2018 | 285 | 0.140 |
Why?
|
Blood Transfusion | 1 | 2023 | 1296 | 0.140 |
Why?
|
Skin Diseases, Parasitic | 1 | 2016 | 13 | 0.140 |
Why?
|
Hospitals, Teaching | 2 | 2014 | 1166 | 0.140 |
Why?
|
RNA, Viral | 2 | 2021 | 2907 | 0.140 |
Why?
|
Amebiasis | 1 | 2016 | 35 | 0.140 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2020 | 370 | 0.140 |
Why?
|
Gene Expression | 2 | 2019 | 7788 | 0.130 |
Why?
|
Tetracyclines | 1 | 2015 | 61 | 0.130 |
Why?
|
Doxycycline | 1 | 2017 | 327 | 0.130 |
Why?
|
Cystitis | 1 | 2015 | 92 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2020 | 849 | 0.130 |
Why?
|
Dosage Compensation, Genetic | 1 | 2016 | 211 | 0.130 |
Why?
|
Bacteriuria | 1 | 2015 | 100 | 0.130 |
Why?
|
Benchmarking | 1 | 2021 | 1034 | 0.130 |
Why?
|
Triazoles | 1 | 2020 | 906 | 0.130 |
Why?
|
Vancomycin | 1 | 2018 | 500 | 0.130 |
Why?
|
Spleen | 3 | 2016 | 2359 | 0.130 |
Why?
|
Structure-Activity Relationship | 2 | 2021 | 3146 | 0.120 |
Why?
|
Organic Chemicals | 1 | 2015 | 212 | 0.120 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 554 | 0.120 |
Why?
|
Immunoassay | 1 | 2018 | 750 | 0.120 |
Why?
|
Enterococcus | 1 | 2015 | 161 | 0.120 |
Why?
|
Fatal Outcome | 2 | 2016 | 1850 | 0.120 |
Why?
|
Neovascularization, Pathologic | 1 | 2004 | 2639 | 0.120 |
Why?
|
Quinazolines | 1 | 2020 | 1356 | 0.120 |
Why?
|
Thiazoles | 1 | 2021 | 1488 | 0.120 |
Why?
|
Pathology, Clinical | 1 | 1997 | 363 | 0.120 |
Why?
|
X Chromosome Inactivation | 4 | 2020 | 223 | 0.120 |
Why?
|
Luminescence | 1 | 2014 | 136 | 0.120 |
Why?
|
Th1 Cells | 1 | 2018 | 1055 | 0.120 |
Why?
|
Indicators and Reagents | 1 | 2014 | 460 | 0.110 |
Why?
|
Biopsy | 2 | 2016 | 6722 | 0.110 |
Why?
|
Endothelium, Vascular | 2 | 2004 | 4454 | 0.110 |
Why?
|
Macrophages, Alveolar | 1 | 2015 | 409 | 0.110 |
Why?
|
DNA Transposable Elements | 1 | 2017 | 749 | 0.110 |
Why?
|
Imidazoles | 1 | 2019 | 1207 | 0.110 |
Why?
|
Opportunistic Infections | 1 | 2016 | 389 | 0.110 |
Why?
|
Computer Systems | 1 | 2014 | 484 | 0.110 |
Why?
|
Cell Membrane Permeability | 1 | 2014 | 589 | 0.100 |
Why?
|
Feces | 1 | 2018 | 1389 | 0.100 |
Why?
|
Equipment Design | 1 | 2020 | 3583 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2020 | 981 | 0.100 |
Why?
|
Male | 16 | 2021 | 349022 | 0.100 |
Why?
|
Urinalysis | 1 | 2014 | 370 | 0.100 |
Why?
|
Algorithms | 3 | 2020 | 13872 | 0.100 |
Why?
|
Fluorescence | 1 | 2014 | 751 | 0.100 |
Why?
|
Embryonic Development | 1 | 2016 | 701 | 0.100 |
Why?
|
Microscopy, Confocal | 1 | 2017 | 1967 | 0.100 |
Why?
|
Pyrazoles | 1 | 2021 | 1963 | 0.100 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2016 | 546 | 0.100 |
Why?
|
Trench Fever | 1 | 2010 | 2 | 0.090 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2124 | 0.090 |
Why?
|
Osteomyelitis | 1 | 2014 | 398 | 0.090 |
Why?
|
Cat-Scratch Disease | 1 | 2010 | 23 | 0.090 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 375 | 0.090 |
Why?
|
Female | 16 | 2021 | 378853 | 0.090 |
Why?
|
Hospitals | 2 | 2020 | 3916 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9387 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2020 | 3007 | 0.090 |
Why?
|
Quality Assurance, Health Care | 1 | 2020 | 2213 | 0.090 |
Why?
|
Urine | 1 | 2011 | 370 | 0.090 |
Why?
|
Penicillin-Binding Proteins | 1 | 2010 | 139 | 0.080 |
Why?
|
Sepsis | 1 | 2023 | 2571 | 0.080 |
Why?
|
Urethra | 1 | 2011 | 401 | 0.080 |
Why?
|
JC Virus | 1 | 2009 | 85 | 0.080 |
Why?
|
Cats | 1 | 2010 | 1000 | 0.080 |
Why?
|
Neoplasms | 2 | 2014 | 21507 | 0.080 |
Why?
|
Middle Aged | 7 | 2021 | 212863 | 0.080 |
Why?
|
Mycobacterium Infections | 1 | 2009 | 122 | 0.080 |
Why?
|
Genes, Tumor Suppressor | 1 | 2013 | 1096 | 0.080 |
Why?
|
Radiography, Thoracic | 1 | 2014 | 1262 | 0.080 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2009 | 135 | 0.080 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2010 | 365 | 0.080 |
Why?
|
Pyridines | 1 | 2019 | 2810 | 0.080 |
Why?
|
Bronchoalveolar Lavage | 1 | 2007 | 120 | 0.080 |
Why?
|
Gastrointestinal Tract | 2 | 2020 | 814 | 0.070 |
Why?
|
Cervix Uteri | 1 | 2011 | 591 | 0.070 |
Why?
|
Hospitals, Urban | 1 | 2009 | 503 | 0.070 |
Why?
|
Myeloproliferative Disorders | 1 | 2013 | 601 | 0.070 |
Why?
|
Atovaquone | 1 | 2006 | 58 | 0.070 |
Why?
|
Membrane Fusion | 1 | 2008 | 271 | 0.070 |
Why?
|
Nitrofurantoin | 2 | 2016 | 19 | 0.070 |
Why?
|
Babesiosis | 1 | 2006 | 90 | 0.060 |
Why?
|
Adult | 7 | 2021 | 213394 | 0.060 |
Why?
|
Splenectomy | 1 | 2006 | 392 | 0.060 |
Why?
|
Referral and Consultation | 1 | 1997 | 3514 | 0.060 |
Why?
|
Mice, SCID | 1 | 2010 | 2716 | 0.060 |
Why?
|
Genotype | 1 | 2019 | 12951 | 0.060 |
Why?
|
Lymphoid Tissue | 1 | 2006 | 455 | 0.060 |
Why?
|
United States | 3 | 2022 | 69573 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7897 | 0.060 |
Why?
|
Ciprofloxacin | 2 | 2016 | 313 | 0.060 |
Why?
|
Cytokines | 1 | 2018 | 7298 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2008 | 19220 | 0.060 |
Why?
|
Time Factors | 3 | 2018 | 40050 | 0.060 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2004 | 821 | 0.060 |
Why?
|
Bacillus anthracis | 1 | 2004 | 123 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2020 | 57650 | 0.060 |
Why?
|
Mice, Inbred Strains | 1 | 2006 | 1837 | 0.060 |
Why?
|
Umbilical Veins | 1 | 2004 | 430 | 0.060 |
Why?
|
Lung | 2 | 2016 | 9782 | 0.060 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 694 | 0.060 |
Why?
|
Myelodysplastic Syndromes | 1 | 2013 | 1345 | 0.050 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2002 | 68 | 0.050 |
Why?
|
Liver | 2 | 2010 | 7449 | 0.050 |
Why?
|
Viral Load | 2 | 2021 | 3299 | 0.050 |
Why?
|
Aged | 6 | 2020 | 162698 | 0.050 |
Why?
|
Ceftriaxone | 1 | 2023 | 167 | 0.050 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2006 | 231 | 0.050 |
Why?
|
Virulence | 1 | 2006 | 1321 | 0.050 |
Why?
|
Young Adult | 3 | 2020 | 56255 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2008 | 1141 | 0.050 |
Why?
|
Clinical Competence | 1 | 1997 | 4671 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2012 | 2583 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2023 | 76631 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2022 | 104 | 0.050 |
Why?
|
HIV Infections | 3 | 2017 | 16764 | 0.050 |
Why?
|
Prednisone | 1 | 2006 | 1560 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1702 | 0.050 |
Why?
|
Culture Media, Conditioned | 1 | 2002 | 532 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12948 | 0.040 |
Why?
|
Antimalarials | 1 | 2006 | 913 | 0.040 |
Why?
|
Cell Survival | 2 | 2010 | 5877 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2004 | 1285 | 0.040 |
Why?
|
Mice, Inbred A | 1 | 1998 | 248 | 0.040 |
Why?
|
Hyphae | 1 | 2017 | 56 | 0.040 |
Why?
|
Spores, Fungal | 1 | 2017 | 95 | 0.040 |
Why?
|
Intracellular Membranes | 1 | 1998 | 389 | 0.040 |
Why?
|
Internship and Residency | 1 | 1997 | 5761 | 0.040 |
Why?
|
RNA, Transfer | 1 | 2020 | 315 | 0.040 |
Why?
|
Transformation, Bacterial | 1 | 2017 | 78 | 0.040 |
Why?
|
Amyloid beta-Peptides | 1 | 2010 | 3579 | 0.040 |
Why?
|
Dogs | 1 | 2002 | 3915 | 0.040 |
Why?
|
Mitosis | 1 | 2002 | 1212 | 0.040 |
Why?
|
Empathy | 1 | 2021 | 471 | 0.040 |
Why?
|
Acanthamoeba castellanii | 1 | 2016 | 10 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2006 | 1777 | 0.030 |
Why?
|
Ampicillin | 1 | 2016 | 138 | 0.030 |
Why?
|
Hemolysis | 1 | 1998 | 420 | 0.030 |
Why?
|
Judgment | 1 | 1997 | 282 | 0.030 |
Why?
|
Kidney | 1 | 2010 | 7144 | 0.030 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2016 | 180 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1904 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2004 | 3504 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1685 | 0.030 |
Why?
|
Specialization | 1 | 1997 | 776 | 0.030 |
Why?
|
Splenomegaly | 1 | 2013 | 190 | 0.030 |
Why?
|
Genes, Lethal | 1 | 2013 | 243 | 0.030 |
Why?
|
Skin | 1 | 2006 | 4324 | 0.030 |
Why?
|
Fear | 1 | 2021 | 1430 | 0.030 |
Why?
|
Mentors | 1 | 1997 | 632 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2012 | 11460 | 0.030 |
Why?
|
Stress, Physiological | 1 | 2020 | 1405 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2017 | 2256 | 0.030 |
Why?
|
Genome, Bacterial | 1 | 2017 | 756 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2016 | 1528 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 4012 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20055 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2012 | 296 | 0.020 |
Why?
|
Primary Myelofibrosis | 1 | 2013 | 213 | 0.020 |
Why?
|
Latex Fixation Tests | 1 | 2010 | 32 | 0.020 |
Why?
|
Xanthenes | 1 | 2010 | 75 | 0.020 |
Why?
|
Cathelicidins | 1 | 2010 | 80 | 0.020 |
Why?
|
Models, Molecular | 1 | 2020 | 5460 | 0.020 |
Why?
|
Artifacts | 1 | 2018 | 1905 | 0.020 |
Why?
|
Urinary Bladder | 1 | 2015 | 1153 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2010 | 7975 | 0.020 |
Why?
|
Contact Lenses, Hydrophilic | 1 | 1989 | 64 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 452 | 0.020 |
Why?
|
Oxazines | 1 | 2010 | 302 | 0.020 |
Why?
|
Cross Infection | 1 | 2017 | 1414 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2021 | 5305 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 2946 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 788 | 0.020 |
Why?
|
Candida albicans | 1 | 2010 | 392 | 0.020 |
Why?
|
Erythrocyte Inclusions | 1 | 2006 | 4 | 0.020 |
Why?
|
Anxiety | 1 | 2021 | 4253 | 0.020 |
Why?
|
Cerebrospinal Fluid | 1 | 2009 | 536 | 0.020 |
Why?
|
Education, Medical | 1 | 1997 | 1712 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 53037 | 0.020 |
Why?
|
Antibodies, Protozoan | 1 | 2006 | 251 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2016 | 3615 | 0.020 |
Why?
|
Boston | 1 | 2017 | 9314 | 0.010 |
Why?
|
Environment | 1 | 2010 | 1110 | 0.010 |
Why?
|
Decision Making | 1 | 1997 | 3854 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2006 | 982 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3922 | 0.010 |
Why?
|
Platelet Count | 1 | 2006 | 780 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15511 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10247 | 0.010 |
Why?
|
Myocardium | 1 | 2016 | 4788 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4205 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3311 | 0.010 |
Why?
|
Bone Marrow | 1 | 2013 | 2933 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2009 | 2602 | 0.010 |
Why?
|
Depression | 1 | 2021 | 7689 | 0.010 |
Why?
|
Genetic Variation | 1 | 2017 | 6539 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2006 | 1537 | 0.010 |
Why?
|
Oxygen | 1 | 2012 | 4158 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2013 | 3364 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6610 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4419 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2010 | 2950 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10455 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2006 | 4522 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9133 | 0.010 |
Why?
|
Inflammation | 1 | 2010 | 10534 | 0.010 |
Why?
|
Brain | 1 | 2010 | 26345 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 35326 | 0.000 |
Why?
|